Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Teufel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Oncoimmunology|May 8, 2015
Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cellsSrinivas Mamidi, Simon Höne, Claudia Teufel, et al.
Mucosal Immunology|August 3, 2021
mTOR signaling mediates ILC3-driven immunopathologyClaudia Teufel, Edit Horvath, Annick Peter, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2022
Autologous Human Immunocompetent White Adipose Tissue-on-ChipJulia Rogal, Julia Roosz, Claudia Teufel, et al.
Cell Stem Cell|May 16, 2024
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cellsTengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 10, 2026
Lymphoid-Tissue-on-Chip Recapitulates Human Antibody Responses In VitroClaudia Teufel, Anna-Sophie Schlemmer, Andrea W Eiken, et al.
Nature Communications|April 15, 2020
Microbiota-induced tissue signals regulate ILC3-mediated antigen presentationFrank Michael Lehmann, Nicole von Burg, Robert Ivanek, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Oncoimmunology|May 8, 2015
Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cellsSrinivas Mamidi, Simon Höne, Claudia Teufel, et al.
Mucosal Immunology|August 3, 2021
mTOR signaling mediates ILC3-driven immunopathologyClaudia Teufel, Edit Horvath, Annick Peter, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 25, 2022
Autologous Human Immunocompetent White Adipose Tissue-on-ChipJulia Rogal, Julia Roosz, Claudia Teufel, et al.
Cell Stem Cell|May 16, 2024
Breast cancer-on-chip for patient-specific efficacy and safety testing of CAR-T cellsTengku Ibrahim Maulana, Claudia Teufel, Madalena Cipriano, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 10, 2026
Lymphoid-Tissue-on-Chip Recapitulates Human Antibody Responses In VitroClaudia Teufel, Anna-Sophie Schlemmer, Andrea W Eiken, et al.
Nature Communications|April 15, 2020
Microbiota-induced tissue signals regulate ILC3-mediated antigen presentationFrank Michael Lehmann, Nicole von Burg, Robert Ivanek, et al.
Pageof 1